Yvonne Greenstreet Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

Yvonne Greenstreet is Chief Executive Officer of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 73,441 shares of ALNY, which is worth approximately $18 Million. The most recent transaction as insider was on Feb 11, 2021, when has been sold 5,416 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.4K
0% 3M change
108.54% 12M change
Total Value Held $18 Million

Yvonne Greenstreet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2021
BUY
Grant, award, or other acquisition
-
5,416 Added 34.6%
10,236 Common Stock
Jan 12 2021
SELL
Open market or private sale
$503,125 $161.0 p/Share
3,125 Reduced 39.33%
4,820 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$131,938 $42.22 p/Share
3,125 Added 28.23%
7,945 Common Stock

Also insider at

PCRX
Pacira BioSciences, Inc. Healthcare
Director
YG

Yvonne Greenstreet

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY